October 2, 2024

Insilico Medicine reports positive results for idiopathic pulmonary fibrosis therapy – PharmaTimes

September 27, 2024

Lung-Targeting Perylenediimide Nanocomposites for Efficient Therapy of Idiopathic Pulmonary Fibrosis – ACS Publications

September 27, 2024

Identification of immune patterns in idiopathic pulmonary fibrosis patients driven by PLA2G7-positive macrophages using an integrated machine learning survival framework – Nature.com

September 25, 2024

Idiopathic Pulmonary Fibrosis (IPF) Workup: Laboratory Studies, Imaging Studies, Other Tests – Medscape Reference

September 18, 2024

Insilico Medicine reports positive Phase IIa results for ISM001-055, a novel first-in-class drug treatment for idiopathic pulmonary fibrosis (IPF) designed using generative AI – EurekAlert